2-[6-(1,3-benzothiazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzothiazole;2-[6-(1,3-benzoxazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzoxazole;2-[1,6-bis(9,9-dimethylacridin-10-yl)-8-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenanthren-3-yl]-[1,3]oxazolo[5,4-b]pyridine;10-[6-(9,9-dimethylacridin-10-yl)-3,8-bis(1-phenylbenzimidazol-2-yl)phenanthren-1-yl]-9,9-dimethylacridine

C242H176N20O4S2 — CID 157063066

IUPAC2-[6-(1,3-benzothiazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzothiazole;2-[6-(1,3-benzoxazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzoxazole;2-[1,6-bis(9,9-dimethylacridin-10-yl)-8-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenanthren-3-yl]-[1,3]oxazolo[5,4-b]pyridine;10-[6-(9,9-dimethylacridin-10-yl)-3,8-bis(1-phenylbenzimidazol-2-yl)phenanthren-1-yl]-9,9-dimethylacridine
SMILESCC1(C)c2ccccc2N(c2cc(-c3nc4ccccc4n3-c3ccccc3)c3ccc4c(N5c6ccccc6C(C)(C)c6ccccc65)cc(-c5nc6ccccc6n5-c5ccccc5)cc4c3c2)c2ccccc21.CC1(C)c2ccccc2N(c2cc(-c3nc4ccccc4o3)c3ccc4c(N5c6ccccc6C(C)(C)c6ccccc65)cc(-c5nc6ccccc6o5)cc4c3c2)c2ccccc21.CC1(C)c2ccccc2N(c2cc(-c3nc4ccccc4s3)c3ccc4c(N5c6ccccc6C(C)(C)c6ccccc65)cc(-c5nc6ccccc6s5)cc4c3c2)c2ccccc21.CC1(C)c2ccccc2N(c2cc(-c3nc4cccnc4o3)c3ccc4c(N5c6ccccc6C(C)(C)c6ccccc65)cc(-c5nc6cccnc6o5)cc4c3c2)c2ccccc21
InChIInChI=1S/C70H52N6.C58H42N4O2.C58H42N4S2.C56H40N6O2/c1-69(2)54-27-11-17-33-60(54)73(61-34-18-12-28-55(61)69)48-43-52-49(53(44-48)68-72-59-32-16-22-38-65(59)75(68)47-25-9-6-10-26-47)39-40-50-51(52)41-45(67-71-58-31-15-21-37-64(58)74(67)46-23-7-5-8-24-46)42-66(50)76-62-35-19-13-29-56(62)70(3,4)57-30-14-20-36-63(57)76;2*1-57(2)42-17-5-11-23-48(42)61(49-24-12-6-18-43(49)57)36-33-40-37(41(34-36)56-60-47-22-10-16-28-54(47)64-56)29-30-38-39(40)31-35(55-59-46-21-9-15-27-53(46)63-55)32-52(38)62-50-25-13-7-19-44(50)58(3,4)45-20-8-14-26-51(45)62;1-55(2)40-15-5-9-21-46(40)61(47-22-10-6-16-41(47)55)34-31-38-35(39(32-34)52-60-45-20-14-28-58-54(45)64-52)25-26-36-37(38)29-33(51-59-44-19-13-27-57-53(44)63-51)30-50(36)62-48-23-11-7-17-42(48)56(3,4)43-18-8-12-24-49(43)62/h5-44H,1-4H3;2*5-34H,1-4H3;5-32H,1-4H3
InChIKeyABNXLBNETUHXKP-UHFFFAOYSA-N
MW3492.34 g/mol
LogP65.43
Rot. Bonds18

About 2-[6-(1,3-benzothiazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzothiazole;2-[6-(1,3-benzoxazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzoxazole;2-[1,6-bis(9,9-dimethylacridin-10-yl)-8-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenanthren-3-yl]-[1,3]oxazolo[5,4-b]pyridine;10-[6-(9,9-dimethylacridin-10-yl)-3,8-bis(1-phenylbenzimidazol-2-yl)phenanthren-1-yl]-9,9-dimethylacridine

2-[6-(1,3-benzothiazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzothiazole;2-[6-(1,3-benzoxazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzoxazole;2-[1,6-bis(9,9-dimethylacridin-10-yl)-8-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenanthren-3-yl]-[1,3]oxazolo[5,4-b]pyridine;10-[6-(9,9-dimethylacridin-10-yl)-3,8-bis(1-phenylbenzimidazol-2-yl)phenanthren-1-yl]-9,9-dimethylacridine (PubChem CID 157063066) has the molecular formula C242H176N20O4S2 and a molecular weight of 3492.34 g/mol. Its IUPAC name is 2-[6-(1,3-benzothiazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzothiazole;2-[6-(1,3-benzoxazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzoxazole;2-[1,6-bis(9,9-dimethylacridin-10-yl)-8-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenanthren-3-yl]-[1,3]oxazolo[5,4-b]pyridine;10-[6-(9,9-dimethylacridin-10-yl)-3,8-bis(1-phenylbenzimidazol-2-yl)phenanthren-1-yl]-9,9-dimethylacridine.

Molecular Properties

Compound Name2-[6-(1,3-benzothiazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzothiazole;2-[6-(1,3-benzoxazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzoxazole;2-[1,6-bis(9,9-dimethylacridin-10-yl)-8-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenanthren-3-yl]-[1,3]oxazolo[5,4-b]pyridine;10-[6-(9,9-dimethylacridin-10-yl)-3,8-bis(1-phenylbenzimidazol-2-yl)phenanthren-1-yl]-9,9-dimethylacridine
PubChem CID157063066
Molecular FormulaC242H176N20O4S2
Molecular Weight3492.34 g/mol
Exact Mass3489.36
IUPAC Name2-[6-(1,3-benzothiazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzothiazole;2-[6-(1,3-benzoxazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzoxazole;2-[1,6-bis(9,9-dimethylacridin-10-yl)-8-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenanthren-3-yl]-[1,3]oxazolo[5,4-b]pyridine;10-[6-(9,9-dimethylacridin-10-yl)-3,8-bis(1-phenylbenzimidazol-2-yl)phenanthren-1-yl]-9,9-dimethylacridine
SMILESCC1(C)c2ccccc2N(c2cc(-c3nc4ccccc4n3-c3ccccc3)c3ccc4c(N5c6ccccc6C(C)(C)c6ccccc65)cc(-c5nc6ccccc6n5-c5ccccc5)cc4c3c2)c2ccccc21.CC1(C)c2ccccc2N(c2cc(-c3nc4ccccc4o3)c3ccc4c(N5c6ccccc6C(C)(C)c6ccccc65)cc(-c5nc6ccccc6o5)cc4c3c2)c2ccccc21.CC1(C)c2ccccc2N(c2cc(-c3nc4ccccc4s3)c3ccc4c(N5c6ccccc6C(C)(C)c6ccccc65)cc(-c5nc6ccccc6s5)cc4c3c2)c2ccccc21.CC1(C)c2ccccc2N(c2cc(-c3nc4cccnc4o3)c3ccc4c(N5c6ccccc6C(C)(C)c6ccccc65)cc(-c5nc6cccnc6o5)cc4c3c2)c2ccccc21
InChIInChI=1S/C70H52N6.C58H42N4O2.C58H42N4S2.C56H40N6O2/c1-69(2)54-27-11-17-33-60(54)73(61-34-18-12-28-55(61)69)48-43-52-49(53(44-48)68-72-59-32-16-22-38-65(59)75(68)47-25-9-6-10-26-47)39-40-50-51(52)41-45(67-71-58-31-15-21-37-64(58)74(67)46-23-7-5-8-24-46)42-66(50)76-62-35-19-13-29-56(62)70(3,4)57-30-14-20-36-63(57)76;2*1-57(2)42-17-5-11-23-48(42)61(49-24-12-6-18-43(49)57)36-33-40-37(41(34-36)56-60-47-22-10-16-28-54(47)64-56)29-30-38-39(40)31-35(55-59-46-21-9-15-27-53(46)63-55)32-52(38)62-50-25-13-7-19-44(50)58(3,4)45-20-8-14-26-51(45)62;1-55(2)40-15-5-9-21-46(40)61(47-22-10-6-16-41(47)55)34-31-38-35(39(32-34)52-60-45-20-14-28-58-54(45)64-52)25-26-36-37(38)29-33(51-59-44-19-13-27-57-53(44)63-51)30-50(36)62-48-23-11-7-17-42(48)56(3,4)43-18-8-12-24-49(43)62/h5-44H,1-4H3;2*5-34H,1-4H3;5-32H,1-4H3
InChIKeyABNXLBNETUHXKP-UHFFFAOYSA-N
XLogP65.43
TPSA217.24 Ų
H-Bond Donors
H-Bond Acceptors26
Rotatable Bonds18
Heavy Atoms268
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003492.34
LogP ≤ 565.43
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 2-[6-(1,3-benzothiazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzothiazole;2-[6-(1,3-benzoxazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzoxazole;2-[1,6-bis(9,9-dimethylacridin-10-yl)-8-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenanthren-3-yl]-[1,3]oxazolo[5,4-b]pyridine;10-[6-(9,9-dimethylacridin-10-yl)-3,8-bis(1-phenylbenzimidazol-2-yl)phenanthren-1-yl]-9,9-dimethylacridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[3-(1,3-benzothiazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenyl]-1,3-benzothiazole;10-[3,5-bis(1-phenylbenzimidazol-2-yl)phenyl]-9,9-dimethylacridine;2-[3-(9,9-dimethylacridin-10-yl)-5-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]-[1,3]oxazolo[5,4-b]pyridine
CID 160956737
9,9-dimethyl-10-[8-[4-(2-phenylbenzimidazol-1-yl)phenyl]dibenzofuran-2-yl]acridine
CID 71007109
2-[6-(1,3-benzothiazol-2-yl)-9-[4-(1-phenylbenzimidazol-2-yl)phenyl]carbazol-3-yl]-6-naphthalen-2-yl-1,3-benzoxazole;2-[6-(1,3-benzothiazol-2-yl)-9-[4-(1-phenylbenzimidazol-2-yl)phenyl]carbazol-3-yl]-6-phenyl-1,3-benzoxazole;2-[6-(1,3-benzoxazol-2-yl)-9-[4-(1-phenylbenzimidazol-2-yl)phenyl]carbazol-3-yl]-1,3-benzoxazole
CID 160563783
2-[3-[4-(3-dibenzofuran-4-ylphenyl)-5,5-dimethylindeno[1,2-d]pyrimidin-2-yl]phenyl]-1,3-benzothiazole;2-[4-[4-(3-dibenzofuran-4-ylphenyl)-5,5-dimethylindeno[1,2-d]pyrimidin-2-yl]phenyl]-1,3-benzoxazole;4-(3-dibenzofuran-4-ylphenyl)-5,5-dimethyl-2-[3-(1-phenylbenzimidazol-2-yl)phenyl]indeno[1,2-d]pyrimidine
CID 161006828
2-(4-tert-butylphenyl)-1,3-benzothiazole;2-(4-tert-butylphenyl)-[1,3]oxazolo[4,5-b]pyridine;2-(4-tert-butylphenyl)-1-phenylbenzimidazole;2-(4-tert-butylphenyl)-[1,3]thiazolo[4,5-b]pyridine
CID 159047395
2-[3-[3-(1,3-benzothiazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenyl]-5-(9,9-dimethylacridin-10-yl)phenyl]-1,3-benzothiazole
CID 129148175
10-[4-(1,3-benzothiazol-2-yl)phenyl]phenoxazine;10-[4-(1,3-benzoxazol-2-yl)phenyl]phenoxazine;2-(4-carbazol-9-ylphenyl)-1,3-benzoxazole
CID 159198907
2-[4-(6,10-diphenylphenanthridin-3-yl)phenyl]-1,3-benzothiazole;2-[4-(6,10-diphenylphenanthridin-3-yl)phenyl]-1,3-benzoxazole;6,10-diphenyl-3-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenanthridine;methane
CID 159000306
2-[4-(9,9-dimethylacridin-10-yl)phenyl]-5,6-diphenylimidazo[4,5-f][1,3]benzothiazole
CID 126731320
9,9-dimethyl-10-phenyl-2-[4-(2-phenylbenzimidazol-1-yl)phenyl]acridine;ethane
CID 158720213
14,14-dimethyl-10-phenyl-21-[4-(1-phenylbenzimidazol-2-yl)phenyl]-10,21-diazapentacyclo[11.8.0.03,11.04,9.015,20]henicosa-1(13),2,4,6,8,11,15,17,19-nonaene
CID 66805197
4-[4-(1,3-benzothiazol-2-yl)phenyl]-6-phenyl-[1,2,5]thiadiazolo[3,4-k]phenanthridine;6-phenyl-4-[4-(1-phenylbenzimidazol-2-yl)phenyl]-[1,2,5]thiadiazolo[3,4-k]phenanthridine;6-phenyl-4-[4-(2-phenylbenzimidazol-1-yl)phenyl]-[1,2,5]thiadiazolo[3,4-k]phenanthridine;2-[4-(6-phenyl-[1,2,5]thiadiazolo[3,4-k]phenanthridin-4-yl)phenyl]-1,3-benzoxazole
CID 167710834

Frequently Asked Questions

What is the IUPAC name of 2-[6-(1,3-benzothiazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzothiazole;2-[6-(1,3-benzoxazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzoxazole;2-[1,6-bis(9,9-dimethylacridin-10-yl)-8-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenanthren-3-yl]-[1,3]oxazolo[5,4-b]pyridine;10-[6-(9,9-dimethylacridin-10-yl)-3,8-bis(1-phenylbenzimidazol-2-yl)phenanthren-1-yl]-9,9-dimethylacridine?
The IUPAC name of 2-[6-(1,3-benzothiazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzothiazole;2-[6-(1,3-benzoxazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzoxazole;2-[1,6-bis(9,9-dimethylacridin-10-yl)-8-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenanthren-3-yl]-[1,3]oxazolo[5,4-b]pyridine;10-[6-(9,9-dimethylacridin-10-yl)-3,8-bis(1-phenylbenzimidazol-2-yl)phenanthren-1-yl]-9,9-dimethylacridine (CID 157063066) is 2-[6-(1,3-benzothiazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzothiazole;2-[6-(1,3-benzoxazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzoxazole;2-[1,6-bis(9,9-dimethylacridin-10-yl)-8-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenanthren-3-yl]-[1,3]oxazolo[5,4-b]pyridine;10-[6-(9,9-dimethylacridin-10-yl)-3,8-bis(1-phenylbenzimidazol-2-yl)phenanthren-1-yl]-9,9-dimethylacridine.
What is the SMILES notation for 2-[6-(1,3-benzothiazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzothiazole;2-[6-(1,3-benzoxazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzoxazole;2-[1,6-bis(9,9-dimethylacridin-10-yl)-8-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenanthren-3-yl]-[1,3]oxazolo[5,4-b]pyridine;10-[6-(9,9-dimethylacridin-10-yl)-3,8-bis(1-phenylbenzimidazol-2-yl)phenanthren-1-yl]-9,9-dimethylacridine?
The canonical SMILES for 2-[6-(1,3-benzothiazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzothiazole;2-[6-(1,3-benzoxazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzoxazole;2-[1,6-bis(9,9-dimethylacridin-10-yl)-8-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenanthren-3-yl]-[1,3]oxazolo[5,4-b]pyridine;10-[6-(9,9-dimethylacridin-10-yl)-3,8-bis(1-phenylbenzimidazol-2-yl)phenanthren-1-yl]-9,9-dimethylacridine is CC1(C)c2ccccc2N(c2cc(-c3nc4ccccc4n3-c3ccccc3)c3ccc4c(N5c6ccccc6C(C)(C)c6ccccc65)cc(-c5nc6ccccc6n5-c5ccccc5)cc4c3c2)c2ccccc21.CC1(C)c2ccccc2N(c2cc(-c3nc4ccccc4o3)c3ccc4c(N5c6ccccc6C(C)(C)c6ccccc65)cc(-c5nc6ccccc6o5)cc4c3c2)c2ccccc21.CC1(C)c2ccccc2N(c2cc(-c3nc4ccccc4s3)c3ccc4c(N5c6ccccc6C(C)(C)c6ccccc65)cc(-c5nc6ccccc6s5)cc4c3c2)c2ccccc21.CC1(C)c2ccccc2N(c2cc(-c3nc4cccnc4o3)c3ccc4c(N5c6ccccc6C(C)(C)c6ccccc65)cc(-c5nc6cccnc6o5)cc4c3c2)c2ccccc21.
What is the InChIKey of 2-[6-(1,3-benzothiazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzothiazole;2-[6-(1,3-benzoxazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzoxazole;2-[1,6-bis(9,9-dimethylacridin-10-yl)-8-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenanthren-3-yl]-[1,3]oxazolo[5,4-b]pyridine;10-[6-(9,9-dimethylacridin-10-yl)-3,8-bis(1-phenylbenzimidazol-2-yl)phenanthren-1-yl]-9,9-dimethylacridine?
The InChIKey is ABNXLBNETUHXKP-UHFFFAOYSA-N. The full InChI is InChI=1S/C70H52N6.C58H42N4O2.C58H42N4S2.C56H40N6O2/c1-69(2)54-27-11-17-33-60(54)73(61-34-18-12-28-55(61)69)48-43-52-49(53(44-48)68-72-59-32-16-22-38-65(59)75(68)47-25-9-6-10-26-47)39-40-50-51(52)41-45(67-71-58-31-15-21-37-64(58)74(67)46-23-7-5-8-24-46)42-66(50)76-62-35-19-13-29-56(62)70(3,4)57-30-14-20-36-63(57)76;2*1-57(2)42-17-5-11-23-48(42)61(49-24-12-6-18-43(49)57)36-33-40-37(41(34-36)56-60-47-22-10-16-28-54(47)64-56)29-30-38-39(40)31-35(55-59-46-21-9-15-27-53(46)63-55)32-52(38)62-50-25-13-7-19-44(50)58(3,4)45-20-8-14-26-51(45)62;1-55(2)40-15-5-9-21-46(40)61(47-22-10-6-16-41(47)55)34-31-38-35(39(32-34)52-60-45-20-14-28-58-54(45)64-52)25-26-36-37(38)29-33(51-59-44-19-13-27-57-53(44)63-51)30-50(36)62-48-23-11-7-17-42(48)56(3,4)43-18-8-12-24-49(43)62/h5-44H,1-4H3;2*5-34H,1-4H3;5-32H,1-4H3.
What are the key properties of 2-[6-(1,3-benzothiazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzothiazole;2-[6-(1,3-benzoxazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzoxazole;2-[1,6-bis(9,9-dimethylacridin-10-yl)-8-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenanthren-3-yl]-[1,3]oxazolo[5,4-b]pyridine;10-[6-(9,9-dimethylacridin-10-yl)-3,8-bis(1-phenylbenzimidazol-2-yl)phenanthren-1-yl]-9,9-dimethylacridine?
2-[6-(1,3-benzothiazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzothiazole;2-[6-(1,3-benzoxazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzoxazole;2-[1,6-bis(9,9-dimethylacridin-10-yl)-8-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenanthren-3-yl]-[1,3]oxazolo[5,4-b]pyridine;10-[6-(9,9-dimethylacridin-10-yl)-3,8-bis(1-phenylbenzimidazol-2-yl)phenanthren-1-yl]-9,9-dimethylacridine has a molecular weight of 3492.34 g/mol, XLogP of 65.43, 18 rotatable bonds, 0 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[6-(1,3-benzothiazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzothiazole;2-[6-(1,3-benzoxazol-2-yl)-3,8-bis(9,9-dimethylacridin-10-yl)phenanthren-1-yl]-1,3-benzoxazole;2-[1,6-bis(9,9-dimethylacridin-10-yl)-8-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenanthren-3-yl]-[1,3]oxazolo[5,4-b]pyridine;10-[6-(9,9-dimethylacridin-10-yl)-3,8-bis(1-phenylbenzimidazol-2-yl)phenanthren-1-yl]-9,9-dimethylacridine is sourced from PubChem (CID 157063066), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).